PARK7 and breast cancer: Moreover, through validation in an independent clinical cohort using blood samples, we confirmed the systemic downregulation of PARK7 mRNA and protein levels in BC patients, providing direct evidence for the tissue consistency of causal associations and further corroborating the reliability of our multi-omics analysis results.